Atalanta Sosnoff Capital’s Bristol-Myers Squibb BMY Stock Holding History

Atalanta Sosnoff Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$328K	Sell	5,696 -576	-9%	-$33.1K	0.01%	94
2026 Q1	$380K	Sell	6,272 -43	-0.7%	-$2.51K	0.01%	92
2025 Q4	$341K	Sell	6,315 -275	-4%	-$13.2K	0.01%	90
2025 Q3	$297K	Sell	6,590 -503	-7%	-$23.5K	0.01%	94
2025 Q2	$328K	Buy	7,093 +301	+4%	+$14.8K	0.01%	89
2025 Q1	$414K	Buy	6,792 +979	+17%	+$57.1K	0.01%	74
2024 Q4	$329K	Buy	5,813 +406	+8%	+$22.7K	0.01%	83
2024 Q3	$280K	Hold	5,407	–	–	0.01%	91
2024 Q2	$225K	Sell	5,407 -210	-4%	-$9.4K	0.01%	85
2024 Q1	$305K	Buy	+5,617	New	+$286K	0.01%	87
2020 Q4	–	Sell	-129,430	Closed	-$7.8M	–	100
2020 Q3	$7.8M	Sell	129,430 -2,639	-2%	-$159K	0.22%	70
2020 Q2	$7.77M	Buy	+132,069	New	+$7.9M	0.23%	69
2019 Q1	–	Sell	-548,824	Closed	-$28.5M	–	89
2018 Q4	$28.5M	Buy	+548,824	New	+$29.5M	1.04%	40
2017 Q1	–	Sell	-520,169	Closed	-$30.4M	–	102
2016 Q4	$30.4M	Buy	+520,169	New	+$28.4M	1.08%	37
2016 Q3	–	Sell	-455,918	Closed	-$33.5M	–	107
2016 Q2	$33.5M	Sell	455,918 -28,502	-6%	-$2.01M	1.12%	35
2016 Q1	$30.9M	Sell	484,420 -30,896	-6%	-$1.95M	0.97%	41
2015 Q4	$35.4M	Buy	515,316 +24,174	+5%	+$1.6M	1.05%	41
2015 Q3	$29.1M	Sell	491,142 -41,642	-8%	-$2.64M	0.93%	45
2015 Q2	$35.5M	Buy	532,784 +466,592	+705%	+$30.7M	0.97%	44
2015 Q1	$4.27M	Buy	+66,192	New	+$4.14M	0.11%	62
2014 Q2	–	Sell	-621,929	Closed	-$32.3M	–	96
2014 Q1	$32.3M	Sell	621,929 -49,380	-7%	-$2.63M	0.72%	44
2013 Q4	$35.7M	Buy	+671,309	New	+$34.2M	0.77%	49

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Atalanta Sosnoff Capital's BMY Position: Q2 2026 in Review

Atalanta Sosnoff Capital reduced its Bristol-Myers Squibb (BMY) stake by 9.2% in Q2 2026, selling an estimated $33.1K and leaving 5,696 shares worth $328K. The position accounts for 0.01% of the portfolio, ranked #94.

Atalanta Sosnoff Capital first reported a position in BMY in Q4 2013 and has held it in 22 quarters since. The position peaked at $35.7M in Q4 2013. 2,502 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Atalanta Sosnoff Capital held 5,696 shares of Bristol-Myers Squibb worth $328K as of Q2 2026.
Atalanta Sosnoff Capital sold 576 Bristol-Myers Squibb shares in Q2 2026, an estimated $33.1K.
Bristol-Myers Squibb made up 0.01% of Atalanta Sosnoff Capital's portfolio in Q2 2026, its #94 holding.
Atalanta Sosnoff Capital first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 22 quarters since.
Atalanta Sosnoff Capital's Bristol-Myers Squibb position peaked at $35.7M in Q4 2013.
2,502 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Atalanta Sosnoff Capital's 13F filing for Q2 2026, filed 12 Aug 2026.